Emerging Therapeutic Approaches to Esophageal Cancer (Volume II)

A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".

Deadline for manuscript submissions: 30 April 2024 | Viewed by 147

Special Issue Editors


E-Mail Website
Guest Editor
1. Birmingham Veterans Affairs Health Care System, Birmingham, AL 35233, USA
2. Department of Surgery, University of Alabama at Birmingham, Birmingham, AL 35233, USA
Interests: microRNA; migration; invasion; apoptosis; PAK4; RAB14
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
1. Birmingham Veterans Affairs Health Care System, Birmingham, AL 35233, USA
2. Department of Surgery, University of Alabama at Birmingham, Birmingham, AL 35233, USA
Interests: esophageal cancer; CUG-BP1; survivin; post translational regulation; cell proliferation
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

This collection is the second edition of the Special Issue “Emerging Therapeutic Approaches to Esophageal Cancer” (https://www.mdpi.com/journal/cancers/special_issues/5NW29L6078).

The incidence of esophageal cancer, one of the least studied and deadliest malignancies, is continuously increasing worldwide. Due to a lack of early diagnosis, it often presents at an advanced stage. Currently, the standard treatment for locally advanced esophageal cancer involves chemotherapy and/or radiation therapy prior to surgery. Despite this trimodal approach, survival remains very poor, with a five-year survival rate of 20%. Thus, alternative therapeutic strategies that serve adjunctive roles to surgery are required in order to improve survival in esophageal cancer patients.

Dr. Pornima Phatak
Dr. James M. Donahue
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Published Papers

This special issue is now open for submission.
Back to TopTop